BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2842616)

  • 21. Effect of trifluoperazine on cyclic nucleotide phosphodiesterase activity in crude homogenates of bovine adrenal medulla.
    Crimaldi AA; Kuo IC; Coffee CJ
    Ann N Y Acad Sci; 1980; 356():367-8. PubMed ID: 6263155
    [No Abstract]   [Full Text] [Related]  

  • 22. Purification of rat heart cyclic nucleotide phosphodiesterase on column of immobilized phenylbutenolide inhibitor.
    Prigent AF; Némoz G; Pacheco H
    Biochem Biophys Res Commun; 1980 Aug; 95(3):1080-9. PubMed ID: 6251827
    [No Abstract]   [Full Text] [Related]  

  • 23. Purification and characterization of high-affinity cyclic adenosine monophosphate phosphodiesterase from dog kidney.
    Thompson WJ; Epstein PM; Strada SJ
    Biochemistry; 1979 Nov; 18(23):5228-37. PubMed ID: 227451
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of somatostatin and dopaminergic agents on bovine pituitary phosphodiesterase activity.
    Nagasaka A; Hidaka H; Nakagawa H; Nakai A; Ohyama T; Aono T; Masunaga R; Iwase K
    Neuroendocrinology; 1986; 43(3):410-5. PubMed ID: 2874515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphodiesterase activities for cyclic nucleotides in nerve endings from the bovine posterior pituitary gland.
    Vale MR; Baker RV; Hope DB
    J Neurochem; 1984 Feb; 42(2):377-83. PubMed ID: 6319599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and kinetic properties of two soluble forms of calmodulin-dependent cyclic nucleotide phosphodiesterase from rat pancreas.
    Vandermeers A; Vandermeers-Piret MC; Rathe J; Christophe J
    Biochem J; 1983 May; 211(2):341-7. PubMed ID: 6307278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Two forms of cyclic nucleotide phosphodiesterase and Ca-dependent protein regulator from rabbit skeletal muscles].
    Lazarevich VG; Men'shikov MIu; Tkachuk VA
    Biokhimiia; 1979 Oct; 44(10):1842-51. PubMed ID: 228768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
    Sobolev AS; Rybalkin SD
    Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE; Quade MM; Schenden JA; Evans DB
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The isolation and characterization of cyclic nucleotide phosphodiesterases from Morris hepatoma 5123tc(h) and rat liver.
    Turnbull JL; Hickie RA
    Int J Biochem; 1984; 16(1):19-29. PubMed ID: 6321259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cyclic nucleotide phosphodiesterase from wheat sprouts. Purification, properties, effect of systemic fungicides].
    Igumenov BL; Etingof RN
    Biokhimiia; 1980 Oct; 45(10):1797-803. PubMed ID: 6263360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C; Schini VB
    Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
    Donnelly TE; Barron B
    Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV; Severin ES
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modes of action of hypoxanthine, inosine and inosine 5'-monophosphate on cyclic nucleotide phosphodiesterase from bovine brain.
    Liang CM; Liu YP; Chabner BA
    Biochem Pharmacol; 1980 Feb; 29(3):277-82. PubMed ID: 6244836
    [No Abstract]   [Full Text] [Related]  

  • 36. Adrenal medullary cyclic nucleotide phosphodiesterase. Subcellular distribution, partial purification and regulation of enzyme activity.
    Egrie JC; Siegel FL
    Biochim Biophys Acta; 1977 Aug; 483(2):348-66. PubMed ID: 196651
    [No Abstract]   [Full Text] [Related]  

  • 37. Biochemical and pharmacological characterization of cyclic nucleotide phosphodiesterase in airway epithelium.
    Rousseau E; Gagnon J; Lugnier C
    Mol Cell Biochem; 1994 Nov; 140(2):171-5. PubMed ID: 7898488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of phosphodiesterase isoenzymes in the ocular glands of the rabbit.
    Millar TJ; Koutavas H
    Adv Exp Med Biol; 1998; 438():153-6. PubMed ID: 9634879
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the soluble phosphodiesterases of chicken gizzard smooth muscle.
    Birnbaum RJ; Head JF
    Biochem J; 1983 Dec; 215(3):627-36. PubMed ID: 6318728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.
    Strada SJ; Martin MW; Thompson WJ
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.